BiotechTube
Home/Treovir/James Markert, MD
JM

James Markert, MD

Founder and Advisor

Treovir

Therapeutic Areas

OncologyPediatric Brain TumorsNeuro-Oncology

Treovir Pipeline

DrugIndicationPhase
G207Recurrent pediatric glioblastoma/gliomaPhase 2

Leadership Team at Treovir

MC
Michael Christini, JD
Founder and CEO
GY
G. Yancey Gillespie, PhD
Founder and CSO
RW
Richard Whitley, MD
Founder and Advisor
View full Treovir profile